Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Mesothelioma: HELP
Articles by Keigo Takagi
Based on 3 articles published since 2008
||||

Between 2008 and 2019, Keigo Takagi wrote the following 3 articles about Mesothelioma.
 
+ Citations + Abstracts
1 Review Malignant pleural mesothelioma presenting as an acute surgical abdomen due to metastatic jejunal perforation. 2010

Gocho, Kyoko / Isobe, Kazutoshi / Kaburaki, Kyohei / Honda, Yoshiko / Mitsuda, Aki / Akasaka, Yoshikiyo / Shimada, Nagato / Takagi, Keigo / Homma, Sakae. ·Department of Respiratory Medicine, Toho University Omori Medical Center, Tokyo. ·Intern Med · Pubmed #20228599.

ABSTRACT: A 52-year-old man was admitted to our hospital in June 2008 presenting abnormal tumor lesions along the left pleura on chest X-ray. The needle-biopsied specimen of the left pleura proved the biphasic type of malignant mesothelioma. However, he complained of acute abdominal pain 7 days after the diagnosis. Chest X-ray revealed free air below the right diaphragm. Emergency surgery revealed a 4-cm perforating jejunal tumor with peritonitis. Histopathology of the resected jejunum demonstrated a metastatic tumor of malignant pleural mesothelioma. This is the first reported case of malignant pleural mesothelioma presenting as an acute surgical abdomen due to jejunal metastasis with perforation.

2 Review [What is the role of pleuropneumonectomy in malignant pleural mesothelioma?]. 2009

Takagi, Keigo. ·Department of Chest Surgery, Toho University Omori Medical Center, Tokyo, Japan. ·Nihon Geka Gakkai Zasshi · Pubmed #19999569.

ABSTRACT: In this report, the results of conventional pleuropneumonectomy in malignant diffuse mesothelioma are reviewed, and the role of this aggressive surgery in multidisciplinary treatment is discussed. The surgical results may improve owing to recent advances in medical technology, although the postoperative survival time after pleuropneumonectomy has remained nearly the same for the past 40 years. The problems with pleuropneumonectomy are high mortality and morbidity rates, high local recurrence rates, and almost the same survival rates as seen after pleurectomy. The indications for this aggressive surgery are limited to stage I, II, and III disease based on an accurate staging system, with induction therapy for macroscopic radical resection and postoperative chemoradiation therapy. In addition, patients must be monitored for the development of major complications perioperatively. The natural history of this disease should be clarified to determine the effectiveness of various forms of therapy. Precise analysis of the accumulated data from many institutions will help to improve the results of pleuropneumonectomy.

3 Review Pleuropneumonectomy: an effective treatment modality for malignant pleural mesothelioma? 2008

Takagi, Keigo. ·Department of Chest Surgery, Toho University Omori Medical Center, Tokyo, Japan. ·Ann Thorac Cardiovasc Surg · Pubmed #18577890.

ABSTRACT: -- No abstract --